Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

@article{Kornstein2006DuloxetineEF,
  title={Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.},
  author={Susan G. Kornstein and Madelaine M. Wohlreich and Craig Mallinckrodt and John G. Watkin and Donna Eileen Stewart},
  journal={The Journal of clinical psychiatry},
  year={2006},
  volume={67 5},
  pages={761-70}
}
OBJECTIVE A number of studies have suggested potential gender differences in the efficacy of antidepressant medications. Pooled data from double-blind, placebo-controlled studies were utilized to compare the efficacy of duloxetine in the treatment of major depressive disorder (MDD) in male and female patients. METHOD Efficacy data were pooled from 7 randomized, double-blind, placebo-controlled clinical trials of duloxetine. These studies represent all available data from U.S. acute-phase… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Surrogate markers of treatment outcome in major depressive disorder.

The international journal of neuropsychopharmacology • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…